Breathing disruptions during sleep widespread in newborns with severe spina bifida

(Press-News.org) Children with spina bifida, a malformation of the spinal cord that can lead to mobility impairments and hydrocephalus — a buildup of fluid in the brain — face significant risk of cognitive difficulties throughout their lives. A new multi-center study led by researchers at Washington University School of Medicine in St. Louis and Michigan Medicine finds that breathing problems during sleep are a widespread but often undetected issue among these babies and raises the possibility that early treatment might significantly improve cognitive development.

The study focused on newborns who had undergone surgery for myelomeningocele, the most severe form of spina bifida. While doctors have known that older children and adults with myelomeningocele often experience sleep disorders, this innovative research reveals that sleep problems begin much earlier than previously recognized and affect more than half of newborns with the condition.

The findings point to a significant opportunity for early intervention: identifying and treating sleep-disordered breathing in these high-risk infants might be an effective way to improve their cognitive development.

The study is published in Pediatrics Jan. 23.

“The vast majority of these newborns with breathing problems would have been completely undetected without the comprehensive sleep studies performed by our multidisciplinary research teams before hospital discharge,” said Renée Shellhaas, MD, the David T. Blasingame Professor of Neurology at WashU Medicine and lead author of the study, who also treats patients at St. Louis Children’s Hospital. “This research demonstrates how bringing together expertise from multiple specialties can identify critical but previously overlooked opportunities to improve outcomes for vulnerable infants.”

Some of the patients in the study were treated at St. Louis Children’s by WashU Medicine pediatric physicians. The hospital provides dedicated care for these patients though the Spina Bifida Clinic and now considers screening high-risk babies to identify newborns with sleep problems and provide early treatment. WashU Medicine is also home to a high-volume center for in utero myelomeningocele repair through the advanced Fetal Care Centerin the Department of Obstetrics & Gynecology at Barnes-Jewish Hospital.

Myelomeningocele happens when the spinal column does not form properly during early fetal development and results in exposure of the spinal cord. It affects around three out of every 10,000 babies born in the U.S. Surgery either while the fetus is still inside the womb or shortly after birth improves motor outcomes and reduces other complications, but patients remain at high risk of social and learning problems as they grow up, and many experience difficulties with memory, attention and information processing.

Older children who have had surgery to repair myelomeningocele as infants are prone to breathing problems during sleep, a condition known as sleep-disordered breathing. This can take different forms, including obstructive sleep apnea, in which the airway is blocked, or central sleep apnea, in which the brain’s drive to breathe is abnormal. If left untreated the cumulative effect of sleep disruption or intermittent low oxygen levels may lead to serious deficits in attention and executive function.

“Sleep-disordered breathing is a significant contributor to behavioral problems and likely to cognitive deficits as well, but it has not been well studied or routinely screened for in newborns,” said coauthor Ronald Chervin, MD, the Michael S. Aldrich Collegiate Professor of Sleep Medicine at the University of Michigan Medical School. “This study addresses a critical gap in our understanding of the prevalence and onset of these sleep and breathing disturbances, and raises the possibility of high-impact interventions that could improve long-term outcomes for these children.”

In collaboration with senior author John Barks, MD, a professor of pediatrics at the University of Michigan Medical School, the researchers worked with experts at nine centers across the U.S., each with large multidisciplinary research teams that were specially assembled for this research. The unprecedented collaboration brought together expertise from neonatology, sleep medicine, neurosurgery, obstetrics, pediatric surgery, psychology, pediatric neurology and other specialties. Over the course of the study these integrated teams measured breathing patterns, brain activity, muscle activity and heart rhythms of 173 newborns who had undergone myelomeningocele repair.

More than half of the babies exhibited some form of sleep-disordered breathing, and babies born preterm were at highest risk, said Shellhaas. This represents an opportunity for early intervention that could benefit a large number of patients, given the effectiveness of current treatments to improve not just breathing but potentially brain function as well.

“What if early diagnosis and treatment of something as seemingly straightforward as sleep-disordered breathing could improve cognitive development for at-risk babies?” said Shellhaas. “It changes everything for these babies. It changes everything for their families. This could be a sea change for the field.”

The research team is continuing to follow the study participants until age two to evaluate their sleep and their cognitive and physical development, which will provide crucial data about the long-term impact of early identification and treatment of sleep-disordered breathing.

Shellhaas said that newborns with myelomeningocele represent a test case for what she and her collaborators expect will be a broader effort to diagnose and treat sleep-related breathing problems in high-risk infants as a way to protect and enhance their neurodevelopment.

“We know that for otherwise healthy children, sleep-disordered breathing results in measurable differences in attention, behavior and quality of life,” said Shellhaas. “For children who have a high risk of sleep problems and who also have a high risk of developmental disabilities, this study identifies a relatively accessible and potentially powerful intervention that could meaningfully improve long-term outcomes.”

Shellhaas RA, Hassan, F, Mason TA, Anadkat J, Bendel-Stenzel E, Eyerly-Webb S, Jon CK, Lloyd RM, Moldenhauer JS, Papanna R, Pascoe JE, Riddle S, Reynolds R, Rocque BG, Simakajornboon N, Treadwell MC, Troxler RB, Youmans LS, Kaciroti NA, McCaffery H, Parmar HA, Merley L, Rau S, Chervin RD, Barks JDE. Sleep-disordered breathing in newborns after myelomeningocele repair. Pediatrics. Jan. 23, 2026.

This work was supported by National Institutes of Health (NIH) grant number R01 HL147261, with additional support from the University of Michigan.

The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Dr. Shellhaas receives royalties from UpToDate for authorship of topics related to neonatal seizures, serves as a consultant for the Epilepsy Study Consortium and receives a stipend for her role as president of the Pediatric Epilepsy Research Foundation. Dr. Chervin receives royalties from UpToDate for authorship and editorial roles related to sleep medicine, serves as a consultant for Eli Lilly & Company through a contract with Michigan Medicine, is named in copyrighted questionnaires licensed by Michigan Medicine to MAPI Research Trust, and serves as president for the International Pediatric Sleep Association.

 

About WashU Medicine

WashU Medicine is a global leader in academic medicine, including biomedical research, patient care and educational programs with more than 3,000 faculty. Its National Institutes of Health (NIH) research funding portfolio is the second largest among U.S. medical schools and has grown 83% since 2016. Together with institutional investment, WashU Medicine commits well over $1 billion annually to basic and clinical research innovation and training. Its faculty practice is consistently among the top five in the country, with more than 2,000 faculty physicians practicing at 130 locations. WashU Medicine physicians exclusively staff Barnes-Jewish and St. Louis Children’s hospitals — the academic hospitals of BJC HealthCare — and Siteman Cancer Center, a partnership between BJC HealthCare and WashU Medicine and the only National Cancer Institute-designated comprehensive cancer center in Missouri. WashU Medicine physicians also treat patients at BJC’s community hospitals in our region. With a storied history in MD/PhD training, WashU Medicine recently dedicated $100 million to scholarships and curriculum renewal for its medical students, and is home to top-notch training programs in every medical subspecialty as well as physical therapy, occupational therapy, and audiology and communications sciences.

END